Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain
Martin E Hale,1 Charles Laudadio,2 Ronghua Yang,2 Arvind Narayana,2 Richard Malamut2 1Gold Coast Research, LLC, Plantation, FL, 2Teva Branded Pharmaceutical Products R & D, Inc., Frazer, PA, USA Abstract: This double-blind, placebo-controlled study evaluated the efficacy and safety of hydro...
Main Authors: | Hale ME, Laudadio C, Yang R, Narayana A, Malamut R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-09-01
|
Series: | Journal of Pain Research |
Online Access: | https://www.dovepress.com/efficacy-and-tolerability-of-a-hydrocodone-extended-release-tablet-for-peer-reviewed-article-JPR |
Similar Items
-
Real-world utilization of once-daily extended-release abuse deterrent formulation of hydrocodone: a comparison with the pre-approval randomized clinical trials
by: Taber L, et al.
Published: (2017-07-01) -
Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations
by: Gould HJ III, et al.
Published: (2015-10-01) -
Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product
by: Pergolizzi, J, et al.
Published: (2018-02-01) -
A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain
by: Nalamachu S, et al.
Published: (2014-11-01) -
Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations
by: Kibbe AH, et al.
Published: (2018-04-01)